论文部分内容阅读
本月关注编者:10多年前,美国FDA批准西布曲明(sibutramine,Meridia)用于肥胖或有其他心血管病风险的超重人群。彼时的研究资料显示,该药能使多数肥胖者体
More than 10 years ago, the U.S. FDA approved sibutramine (Meridia) for overweight people at risk for obesity or other cardiovascular conditions. The research data showed that the drug can make most obese people